{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:28:29Z","timestamp":1787509709257,"version":"build-2736575974"},"reference-count":132,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammatory bowel diseases (IBDs) with the subtypes ulcerative colitis (UC) and Crohn disease (CD), are chronic autoimmune inflammatory disorders of the gastrointestinal tract. Cytokines are associated with the development and progression in pediatric IBD. We measured cytokine levels in pediatric IBD patients to assess their potential function as biomarkers in disease assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>In this prospective cohort study, we enrolled 33 children with IBD. All patients were in stable remission for 3 months on enrollment. Patients who developed a relapse within six months after enrollment were classified as relapsers. Blood sampling was performed at enrolment and for relapsers in relapse and post-relapse. Serum concentrations of 14 cytokines, chemokines and growth factors (IL-1\u03b1, IL-1\u03b2, IL-6, IL-12p40, IP-10, TNF-\u03b1, IFN-\u03b3, IL-10, IL-8, MIP-1\u03b1, MCP-1, MCP-3, G-CSF, GM-CSF) were measured simultaneously using multiplex bead-based sandwich immunoassay on Luminex 100 system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MCP-1 was significantly higher in CD patients compared to UC patients at each disease stage: stable remission (P&lt;0.048), unstable remission (P&lt;0.013), relapse (P&lt;0.026) and post-relapse (P&lt;0.024). G-CSF was significantly increased in UC patients developing a relapse and in post-relapse stage compared to UC patients in remission (P&lt;0.02 and p&lt;0.03, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MCP-1 showed potential as a diagnostic biomarker in CD patients independent of disease activity as it was able to discriminate between subtypes of pediatric IBD. In UC patients, G-CSF was significantly elevated in relapsers indicating its use and role as a potential prognostic biomarker.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0288147","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T13:26:40Z","timestamp":1699018000000},"page":"e0288147","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease"],"prefix":"10.1371","volume":"18","author":[{"given":"Andrea","family":"Ott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1866-4492","authenticated-orcid":true,"given":"Erol","family":"Tutdibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybelle","family":"Goedicke-Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Sch\u00f6pe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zemlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-1868","authenticated-orcid":true,"given":"Nasenien","family":"Nourkami-Tutdibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"pone.0288147.ref001","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.gastro.2021.04.063","article-title":"Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User\u2019s Guide for Adult and Pediatric Gastroenterologists","author":"M Agrawal","year":"2021","journal-title":"Gastroenterology. W.B. Saunders"},{"key":"pone.0288147.ref002","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.3748\/wjg.v18.i41.5862","article-title":"Crohn\u2019s and colitis in children and adolescents","volume":"18","author":"AS Day","year":"2012","journal-title":"World J Gastroenterol"},{"key":"pone.0288147.ref003","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory bowel disease in children and adolescents","author":"MJ Rosen","year":"2015","journal-title":"JAMA Pediatrics. American Medical Association"},{"key":"pone.0288147.ref004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2352-4642(17)30017-2","article-title":"Early-onset paediatric inflammatory bowel disease","author":"JJ Ashton","year":"2017","journal-title":"The Lancet Child and Adolescent Health. Elsevier B.V."},{"key":"pone.0288147.ref005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000501519","article-title":"An Overview of Inflammatory Bowel Disease Unclassified in Children","volume":"4","author":"LE Thurgate","year":"2019","journal-title":"Inflamm Intest Dis"},{"key":"pone.0288147.ref006","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of Inflammatory Bowel Diseases. Longo DL, editor","volume":"383","author":"JT Chang","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"pone.0288147.ref007","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.3748\/wjg.v12.i38.6102","article-title":"Recent trends in the epidemiology of inflammatory bowel diseases: Up or down?","author":"PL Lakatos","year":"2006","journal-title":"World Journal of Gastroenterology. Baishideng Publishing Group Co"},{"key":"pone.0288147.ref008","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.3748\/wjg.14.5491","article-title":"Inflammatory bowel diseases: A disease (s) of modern times? Is incidence still increasing?","author":"CS Gismera","year":"2008","journal-title":"World Journal of Gastroenterology. Baishideng Publishing Group Co"},{"key":"pone.0288147.ref009","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MPG.0b013e318218be35","article-title":"Epidemiology of inflammatory bowel disease: Is there a shift towards onset at a younger age?","volume":"53","author":"CP Braegger","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"pone.0288147.ref010","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ibd.21797","article-title":"Rising incidence of pediatric inflammatory bowel disease in Scotland","author":"P Henderson","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"key":"pone.0288147.ref011","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/archdischild-2013-305419","article-title":"Rising incidence of paediatric inflammatory bowel disease (PIBD) in Wessex, Southern England","volume":"99","author":"JJ Ashton","year":"2014","journal-title":"Arch Dis Child"},{"key":"pone.0288147.ref012","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/MPG.0000000000001547","article-title":"Temporal Trend of Pediatric Inflammatory Bowel Disease: Analysis of National Registry Data 2004 to 2013","volume":"65","author":"T Ishige","year":"2017","journal-title":"Japan. J Pediatr Gastroenterol Nutr"},{"key":"pone.0288147.ref013","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"SC Ng","year":"2017","journal-title":"The Lancet"},{"key":"pone.0288147.ref014","article-title":"Inflammatory bowel disease: Genetics, epigenetics, and pathogenesis. Frontiers in Immunology","author":"I Loddo","year":"2015","journal-title":"Frontiers Research Foundation"},{"key":"pone.0288147.ref015","first-page":"14","article-title":"Inflammatory bowel disease: the difference between children and adults","author":"J Kelsen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0288147.ref016","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn\u2019s disease and ulcerative colitis phenotypes: A genetic association study","volume":"387","author":"I Cleynen","year":"2016","journal-title":"The Lancet"},{"key":"pone.0288147.ref017","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.203","article-title":"Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease","volume":"40","author":"S Kugathasan","year":"2008","journal-title":"Nat Genet"},{"key":"pone.0288147.ref018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41435-018-0015-2","article-title":"Genetic variants and pathways implicated in a pediatric inflammatory bowel disease cohort","volume":"20","author":"KA Shaw","year":"2019","journal-title":"Genes Immun"},{"key":"pone.0288147.ref019","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41586-020-2025-2","article-title":"Pathway paradigms revealed from the genetics of inflammatory bowel disease","author":"DB Graham","year":"2020","journal-title":"Nature. Nature Research"},{"key":"pone.0288147.ref020","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fped.2020.618918","article-title":"Advanced Understanding of Monogenic Inflammatory Bowel Disease","volume":"8","author":"R Nambu","year":"2021","journal-title":"Front Pediatr"},{"key":"pone.0288147.ref021","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/gutjnl-2014-307477","article-title":"Comparing histological activity indexes in UC","volume":"64","author":"A Bressenot","year":"2015","journal-title":"Gut"},{"key":"pone.0288147.ref022","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2014.07.023","article-title":"The diagnostic approach to monogenic very early onset inflammatory bowel disease","author":"HH Uhlig","year":"2014","journal-title":"Gastroenterology. W.B. Saunders"},{"key":"pone.0288147.ref023","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MIB.0000000000000614","article-title":"From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease","author":"HH Uhlig","year":"2016","journal-title":"Inflammatory Bowel Diseases. Lippincott Williams and Wilkins"},{"key":"pone.0288147.ref024","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.3389\/fimmu.2021.675186","article-title":"The Growing Need to Understand Very Early Onset Inflammatory Bowel Disease","volume":"12","author":"HB Zheng","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0288147.ref025","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3748\/wjg.v24.i25.2741","article-title":"Current global trends in the incidence of pediatric-onset inflammatory bowel disease","author":"J S\u00fdkora","year":"2018","journal-title":"World Journal of Gastroenterology. Baishideng Publishing Group Co"},{"key":"pone.0288147.ref026","first-page":"16","article-title":"Incidence trends of pediatric onset inflammatory bowel disease in the years 2000\u20132009 in Saxony, Germany\u2013first results of the Saxon Pediatric IBD Registry","author":"I Kern","year":"2021","journal-title":"PLoS One"},{"key":"pone.0288147.ref027","first-page":"17","article-title":"Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000\u20132014 \u2013a 15-year evaluation of trends","author":"I Kern","year":"2022","journal-title":"PLoS One"},{"key":"pone.0288147.ref028","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cgh.2019.06.030","article-title":"Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review","volume":"18","author":"PG Kotze","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"pone.0288147.ref029","first-page":"21","article-title":"Impact of diagnostic delay to the clinical presentation and associated factors in pediatric inflammatory bowel disease: a retrospective study","author":"E Sulkanen","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"pone.0288147.ref030","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/ibd\/izaa341","article-title":"Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus Study","volume":"27","author":"MY Stulman","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0288147.ref031","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.3748\/wjg.v28.i30.4174","article-title":"Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil","volume":"28","author":"OS Cassol","year":"2022","journal-title":"World J Gastroenterol"},{"key":"pone.0288147.ref032","article-title":"Global Hospitalization Trends for Crohn\u2019s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses","author":"MJ Buie","year":"2022","journal-title":"Clinical Gastroenterology and Hepatology. W.B. Saunders"},{"key":"pone.0288147.ref033","first-page":"13","article-title":"Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study","author":"AB Quaresma","year":"2022","journal-title":"The Lancet Regional Health\u2014Americas"},{"key":"pone.0288147.ref034","first-page":"E28624","article-title":"Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean","volume":"101","author":"JK Yamamoto-Furusho","year":"2022","journal-title":"Medicine (United States)"},{"key":"pone.0288147.ref035","first-page":"449","article-title":"Psychosocial issues in pediatric inflammatory bowel disease: Report of the north american society for pediatric gastroenterology, hepatology, and nutrition. Journal of Pediatric Gastroenterology and Nutrition","author":"LM MacKner","year":"2013","journal-title":"NIH Public Access"},{"key":"pone.0288147.ref036","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/jcag\/gwy056","article-title":"The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD","volume":"2","author":"MW Carroll","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"key":"pone.0288147.ref037","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MPG.0000000000003667","article-title":"Growth After Menarche in Pediatric Inflammatory Bowel Disease","volume":"76","author":"V. Salguero M","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"pone.0288147.ref038","first-page":"158","article-title":"Childhood onset inflammatory bowel disease: Predictors of delayed diagnosis from the CEDATA German-language pediatric inflammatory bowel disease registry","author":"A Timmer","year":"2011","journal-title":"Journal of Pediatrics"},{"key":"pone.0288147.ref039","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1007\/s10620-022-07452-5","article-title":"Diagnostic Delay in Pediatric Inflammatory Bowel Disease: A Systematic Review","volume":"67","author":"A Ajbar","year":"2022","journal-title":"Dig Dis Sci"},{"key":"pone.0288147.ref040","article-title":"Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease","author":"N Jayasooriya","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0288147.ref041","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/MIB.0000000000000085","article-title":"Role of genetics in pediatric inflammatory bowel disease","author":"DT Okou","year":"2014","journal-title":"Inflammatory Bowel Diseases. Lippincott Williams and Wilkins"},{"key":"pone.0288147.ref042","first-page":"370","article-title":"Endoscopic diagnosis and differentiation of inflammatory bowel disease","author":"JM Lee","year":"2016","journal-title":"Clinical Endoscopy. Korean Society of Gastrointestinal Endoscopy"},{"key":"pone.0288147.ref043","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.3748\/wjg.v24.i35.4014","article-title":"Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment","author":"CM Spiceland","year":"2018","journal-title":"World Journal of Gastroenterology. Baishideng Publishing Group Co"},{"key":"pone.0288147.ref044","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1053\/j.gastro.2019.06.018","article-title":"Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases","volume":"157","author":"PS Dulai","year":"2019","journal-title":"Gastroenterology"},{"key":"pone.0288147.ref045","first-page":"1","article-title":"Is intestinal ultrasound ready to be used as standard monitoring tool in daily practice and as endpoint in clinical trials?","author":"C Maaser","year":"2021","journal-title":"Journal of Crohn\u2019s and Colitis. Oxford University Press"},{"key":"pone.0288147.ref046","article-title":"Diagnostic Utility of Non-invasive Tests for Inflammatory Bowel Disease: An Umbrella Review. Frontiers in Medicine","author":"JT Shi","year":"2022","journal-title":"Frontiers Media S.A."},{"key":"pone.0288147.ref047","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00431-021-04315-5","article-title":"The child\u2019s perception on monitoring inflammatory bowel disease activity","volume":"181","author":"EA van Wassenaer","year":"2022","journal-title":"Eur J Pediatr"},{"key":"pone.0288147.ref048","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00005176-199202000-00017","article-title":"Relationship of common laboratory parameters to the activity of crohn\u2019s disease in children","volume":"14","author":"JS Hyams","year":"1992","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"pone.0288147.ref049","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0016-5085(99)70173-3","article-title":"Assessing activity of pediatric Crohn\u2019s disease: Which index to use?","volume":"116","author":"A Otley","year":"1999","journal-title":"Gastroenterology"},{"key":"pone.0288147.ref050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00005176-200301000-00016","article-title":"Pediatric Crohn disease activity index: Responsive to short-term change","volume":"36","author":"PS Kundhal","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"pone.0288147.ref051","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/01.mpg.0000183350.46795.42","article-title":"Evaluation of the pediatric Crohn disease activity index: A prospective multicenter experience","volume":"41","author":"J Hyams","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"pone.0288147.ref052","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study","volume":"133","author":"D Turner","year":"2007","journal-title":"Gastroenterology"},{"key":"pone.0288147.ref053","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/ajg.2010.143","article-title":"Appraisal of the pediatric crohn\u2019s disease activity index on four prospectively collected datasets: Recommended cutoff values and clinimetric properties","volume":"105","author":"D Turner","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"pone.0288147.ref054","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1572-0241.2001.03618.x","article-title":"Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease","volume":"96","author":"MC Dubinsky","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"pone.0288147.ref055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/PL00000223","article-title":"Tissue cytokine and chemokine expression in inflammatory bowel disease","volume":"50","author":"G McCormack","year":"2001","journal-title":"Inflammation Research"},{"key":"pone.0288147.ref056","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","author":"MF Neurath","year":"2014","journal-title":"Nature Reviews Immunology. Nature Publishing Group"},{"key":"pone.0288147.ref057","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3748\/wjg.14.4280","article-title":"Role of cytokines in inflammatory bowel disease","author":"F Sanchez-Mu\u00f1oz","year":"2008","journal-title":"World Journal of Gastroenterology. Baishideng Publishing Group Co;"},{"key":"pone.0288147.ref058","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","article-title":"Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases","volume":"140","author":"W Strober","year":"2011","journal-title":"Gastroenterology"},{"key":"pone.0288147.ref059","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.10.008","article-title":"Chemokine and cytokine levels in inflammatory bowel disease patients","volume":"77","author":"UP Singh","year":"2016","journal-title":"Cytokine"},{"key":"pone.0288147.ref060","first-page":"98","article-title":"Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease","author":"ML Martinez-Fierro","year":"2019","journal-title":"Medicine (United States)."},{"key":"pone.0288147.ref061","first-page":"10","article-title":"Serological cytokine signature in paediatric patients with inflammatory bowel disease impacts diagnosis","author":"M Tatsuki","year":"2020","journal-title":"Sci Rep"},{"key":"pone.0288147.ref062","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fped.2020.00400","article-title":"Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease","volume":"8","author":"W El-Matary","year":"2020","journal-title":"Front Pediatr"},{"key":"pone.0288147.ref063","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10208","article-title":"Intestinal homeostasis and its breakdown in inflammatory bowel disease","author":"KJ Maloy","year":"2011","journal-title":"Nature. Nature"},{"key":"pone.0288147.ref064","first-page":"104835","article-title":"Cytokines in inflammatory bowel diseases\u2013Update 2020","author":"M Leppkes","year":"2020","journal-title":"Pharmacological Research. Academic Press"},{"key":"pone.0288147.ref065","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The Many Roles of Chemokines and Chemokine Receptors in Inflammation","volume":"354","author":"IF Charo","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"pone.0288147.ref066","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ibd.21316","article-title":"Intestinal growth factors: Potential use in the treatment of inflammatory bowel disease and their role in mucosal healing. Inflammatory Bowel Diseases","author":"K Krishnan","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0288147.ref067","first-page":"822","article-title":"VEGF, basic-FGF, and TGF-beta in Crohn\u2019s disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation","volume":"96","author":"S Kanazawa","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"pone.0288147.ref068","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1572-0241.2005.40819.x","article-title":"Protein Microarray Analysis of Disease Activity in Pediatric Inflammatory Bowel Disease Demonstrates Elevated Serum PLGF, IL-7, TGF-\u03b21, and IL-12p40 Levels in Crohn\u2019s Disease and Ulcerative Colitis Patients in Remission versus Active Disease","volume":"100","author":"HA Kader","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"pone.0288147.ref069","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.dld.2008.02.010","article-title":"Increased expression of VEGF and CD146 in patients with inflammatory bowel disease","volume":"40","author":"G Tsiolakidou","year":"2008","journal-title":"Digestive and Liver Disease"},{"key":"pone.0288147.ref070","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1572-0241.1999.01145.x","article-title":"Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time","volume":"94","author":"B Moum","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"pone.0288147.ref071","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/gut.34.3.375","article-title":"Early mucosal changes in Crohn\u2019s disease","volume":"34","author":"EA Sankey","year":"1993","journal-title":"Gut"},{"key":"pone.0288147.ref072","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ibd.21493","article-title":"Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification","volume":"17","author":"A Levine","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0288147.ref073","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ajg.2010.481","article-title":"Consensus for managing acute severe ulcerative colitis in children: A systematic review and joint statement from ECCO, ESPGHAN, and the porto IBD working group of ESPGHAN","author":"D Turner","year":"2011","journal-title":"American Journal of Gastroenterology"},{"key":"pone.0288147.ref074","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MPG.0b013e3182662233","article-title":"Management of pediatric ulcerative colitis: Joint ECCO and ESPGHAN evidence-based consensus guidelines","volume":"55","author":"D Turner","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"pone.0288147.ref075","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","article-title":"Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease","volume":"8","author":"FM Ruemmele","year":"2014","journal-title":"J Crohns Colitis"},{"key":"pone.0288147.ref076","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1016\/S1873-9946(14)50148-1","article-title":"-32: How the ECCO-ESPGHAN Consensus Guidelines guide the management of paediatric Crohn\u2019s disease","volume":"8","author":"F. Ruemmele","year":"2014","journal-title":"J Crohns Colitis"},{"key":"pone.0288147.ref077","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1055\/s-0034-1385199","article-title":"Aktualisierte S3-Leitlinie\u2014\u201cDiagnostik und Therapie des Morbus Crohn\u201d 2014 1: AWMF-Registriernummer: 021\u2013004","volume":"52","author":"JC Prei\u00df","year":"2014","journal-title":"Z Gastroenterol"},{"key":"pone.0288147.ref078","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1055\/s-0031-1281666","article-title":"Aktualisierte Leitlinie zur Diagnostik und Therapie derColitis ulcerosa 2011 Ergebnisse einer Evidenzbasierten Konsensuskonferenz: AWMF- Registriernummer: 021\/009","volume":"49","author":"A Dignass","year":"2011","journal-title":"Z Gastroenterol"},{"key":"pone.0288147.ref079","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ecco-jcc\/jjaa161","article-title":"The Medical Management of Paediatric Crohn\u2019s Disease: An ECCO-ESPGHAN Guideline Update","volume":"15","author":"PF Van Rheenen","year":"2021","journal-title":"J Crohns Colitis"},{"key":"pone.0288147.ref080","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents","volume":"58","author":"A Levine","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"pone.0288147.ref081","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"L Jostins","year":"2012","journal-title":"Nature"},{"key":"pone.0288147.ref082","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"JZ Liu","year":"2015","journal-title":"Nat Genet"},{"key":"pone.0288147.ref083","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease","volume":"49","author":"KM De Lange","year":"2017","journal-title":"Nat Genet"},{"key":"pone.0288147.ref084","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature22969","article-title":"Fine-mapping inflammatory bowel disease loci to single-variant resolution","volume":"547","author":"H Huang","year":"2017","journal-title":"Nature"},{"key":"pone.0288147.ref085","first-page":"9","article-title":"IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes","author":"Y Momozawa","year":"2018","journal-title":"Nat Commun"},{"key":"pone.0288147.ref086","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41575-019-0118-x","article-title":"Redefining the IBDs using genome-scale molecular phenotyping","author":"TS Furey","year":"2019","journal-title":"Nature Reviews Gastroenterology and Hepatology. Nature Publishing Group"},{"key":"pone.0288147.ref087","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41575-022-00593-y","article-title":"Multiomics to elucidate inflammatory bowel disease risk factors and pathways","author":"M Agrawal","year":"2022","journal-title":"Nature Reviews Gastroenterology and Hepatology. Nature Research"},{"key":"pone.0288147.ref088","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/1074-7613(94)90045-0","article-title":"Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells","volume":"1","author":"F Powrie","year":"1994","journal-title":"Immunity"},{"key":"pone.0288147.ref089","first-page":"567","article-title":"The role of TH1\/TH2 polarization in mucosal immunity","author":"MF Neurath","year":"2002","journal-title":"Nature Medicine. Nature Publishing Group"},{"key":"pone.0288147.ref090","first-page":"289","article-title":"All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD\u2013A Clinical Perspective. Immunotargets","volume":"9","author":"A Jefremow","year":"2020","journal-title":"Ther"},{"key":"pone.0288147.ref091","first-page":"10","article-title":"Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease","author":"P Krawiec","year":"2020","journal-title":"Sci Rep"},{"key":"pone.0288147.ref092","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ibd.21349","article-title":"Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends","author":"EI Benchimol","year":"2011","journal-title":"Inflammatory Bowel Diseases. Inflamm Bowel Dis"},{"key":"pone.0288147.ref093","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ajg.2017.97","article-title":"Trends in epidemiology of pediatric inflammatory bowel disease in Canada: Distributed network analysis of multiple population-based provincial health administrative databases","volume":"112","author":"EI Benchimol","year":"2017","journal-title":"American Journal of Gastroenterology"},{"key":"pone.0288147.ref094","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2021.12.282","article-title":"Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review","volume":"162","author":"ME Kuenzig","year":"2022","journal-title":"Gastroenterology"},{"key":"pone.0288147.ref095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4137\/CGast.S20612","article-title":"Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn\u2019s Colitides.","volume":"8","author":"OY Korolkova","year":"2015","journal-title":"Clin Med Insights Gastroenterol"},{"key":"pone.0288147.ref096","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/gutjnl-2020-321731","article-title":"Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance","volume":"70","author":"D Aschenbrenner","year":"2021","journal-title":"Gut"},{"key":"pone.0288147.ref097","doi-asserted-by":"crossref","first-page":"65","DOI":"10.14740\/gr740w","article-title":"IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease","volume":"10","author":"L Zhu","year":"2017","journal-title":"Gastroenterology Res"},{"key":"pone.0288147.ref098","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1111\/j.1572-0241.2002.06030.x","article-title":"Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients","volume":"97","author":"KA Brown","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"pone.0288147.ref099","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.crohns.2012.12.012","article-title":"Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis","volume":"7","author":"E Wine","year":"2013","journal-title":"J Crohns Colitis"},{"key":"pone.0288147.ref100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10620-006-9322-y","article-title":"Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients","volume":"52","author":"KP Reddy","year":"2007","journal-title":"Dig Dis Sci"},{"key":"pone.0288147.ref101","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/MEG.0000000000001538","article-title":"Time to antibody detection and associated factors for presence of anti-drug antibodies in pediatric inflammatory bowel disease patients treated with anti-TNF therapy","volume":"31","author":"J Moses","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"pone.0288147.ref102","article-title":"Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers","author":"G Cui","year":"2021","journal-title":"EBioMedicine. Elsevier B.V."},{"key":"pone.0288147.ref103","first-page":"10","article-title":"Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn\u2019s Disease","author":"Y Kwon","year":"2022","journal-title":"Biomedicines"},{"key":"pone.0288147.ref104","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5863\/1551-6776-27.1.63","article-title":"Comparison of Timing to Develop Anti-Drug Antibodies to Infliximab and Adalimumab Between Adult and Pediatric Age Groups","volume":"27","author":"MC Trotta","year":"2022","journal-title":"Males and Females. Journal of Pediatric Pharmacology and Therapeutics"},{"key":"pone.0288147.ref105","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/ajg.2013.360","article-title":"Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease","volume":"108","author":"J D\u00e4britz","year":"2013","journal-title":"American Journal of Gastroenterology"},{"key":"pone.0288147.ref106","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/MPG.0000000000001851","article-title":"Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease","volume":"66","author":"SS Wright","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"pone.0288147.ref107","first-page":"9","article-title":"Neutrophil GM-CSF signaling in inflammatory bowel disease patients is influenced by non-coding genetic variants","author":"S Venkateswaran","year":"2019","journal-title":"Sci Rep"},{"key":"pone.0288147.ref108","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13023-020-01503-8","article-title":"Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib","volume":"15","author":"SC Gr\u00fcnert","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0288147.ref109","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/JLB.5AB1219-699RR","article-title":"Neutrophil dysfunction triggers inflammatory bowel disease in G6PC3 deficiency","volume":"109","author":"A Goenka","year":"2021","journal-title":"J Leukoc Biol"},{"key":"pone.0288147.ref110","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/jlb.59.6.804","article-title":"Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa","volume":"59","author":"MC Grimm","year":"1996","journal-title":"J Leukoc Biol"},{"key":"pone.0288147.ref111","first-page":"291","article-title":"Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells","author":"WI Khan","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"pone.0288147.ref112","first-page":"19","article-title":"The immunopathology of chemotactic cytokines","volume-title":"Advances in Experimental Medicine and Biology","author":"RM Stricter","year":"1993"},{"key":"pone.0288147.ref113","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jlb.59.1.67","article-title":"Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1","volume":"59","author":"P Proost","year":"1996","journal-title":"J Leukoc Biol"},{"key":"pone.0288147.ref114","first-page":"71","article-title":"The production of monocyte chemoattractant protein-1 (MCP-1)\/CCL2 in tumor microenvironments","author":"T. Yoshimura","year":"2017","journal-title":"Cytokine. Academic Press"},{"key":"pone.0288147.ref115","first-page":"2759","article-title":"More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis. Frontiers in Immunology","author":"M Gschwandtner","year":"2019","journal-title":"Frontiers Media S.A."},{"key":"pone.0288147.ref116","article-title":"COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases","author":"L Cheng","year":"2021","journal-title":"Proceedings of the National Academy of Sciences of the United States of America. National Academy of Sciences"},{"key":"pone.0288147.ref117","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.3389\/fimmu.2021.763292","article-title":"Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19","volume":"12","author":"L Ling","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0288147.ref118","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/gut.52.9.1257","article-title":"Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells","volume":"52","author":"S Futagami","year":"2003","journal-title":"Gut"},{"key":"pone.0288147.ref119","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.4049\/jimmunol.180.5.2886","article-title":"The Role for Monocyte Chemoattractant Protein-1 in the Generation and Function of Memory CD8 + T Cells","volume":"180","author":"T Wang","year":"2008","journal-title":"The Journal of Immunology"},{"key":"pone.0288147.ref120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/ard.62.2.113","article-title":"Interleukin 7 stimulates tumour necrosis factor \u03b1 and Th 1 cytokine production in joints of patients with rheumatoid arthritis","volume":"62","author":"JAG Van Roon","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"pone.0288147.ref121","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1002\/ibd.22914","article-title":"Deficit of Interleukin-7 in Serum of Patients with Crohn\u02bcs Disease","volume":"19","author":"JC Andreu-Ballester","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0288147.ref122","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1074-7613(02)00424-7","article-title":"G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood","volume":"17","author":"CL Semerad","year":"2002","journal-title":"Immunity"},{"key":"pone.0288147.ref123","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/PL00000283","article-title":"Molecular aspects of anti-inflammatory action of G-CSF","author":"EM Boneberg","year":"2002","journal-title":"Inflammation Research. Birkhauser Verlag Basel"},{"key":"pone.0288147.ref124","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1043-4666(03)00149-2","article-title":"Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor","volume":"23","author":"H Egi","year":"2003","journal-title":"Cytokine"},{"key":"pone.0288147.ref125","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1111\/j.1462-5822.2006.00763.x","article-title":"G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages","volume":"8","author":"SO Kim","year":"2006","journal-title":"Cell Microbiol"},{"key":"pone.0288147.ref126","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ibd.20808","article-title":"Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease","volume":"15","author":"AJ Martins","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0288147.ref127","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2249.2008.03799.x","article-title":"Successful granulocyte-colony stimulating factor treatment of Crohn\u2019s disease is associated with the appearance of circulating interleukin-10- producing T cells and increased lamina propria plasmacytoid dendritic cells","volume":"155","author":"PJ Mannon","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"pone.0288147.ref128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mpd.2000.105232","article-title":"Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: Results of the European study on glycogen storage disease type I","volume":"137","author":"G Visser","year":"2000","journal-title":"Journal of Pediatrics"},{"key":"pone.0288147.ref129","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s00431-002-1010-0","article-title":"Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1","volume":"161","author":"G Visser","year":"2002","journal-title":"Eur J Pediatr"},{"key":"pone.0288147.ref130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13052-021-01100-w","article-title":"Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report","volume":"47","author":"A Rossi","year":"2021","journal-title":"Ital J Pediatr"},{"key":"pone.0288147.ref131","doi-asserted-by":"crossref","first-page":"11235","DOI":"10.1073\/pnas.1706053114","article-title":"Granulocyte-colony\u2013stimulating factor (G-CSF) signaling in spinal microglia drives visceral sensitization following colitis","volume":"114","author":"L Basso","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0288147.ref132","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/gut.2004.043406","article-title":"Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn\u2019s disease","volume":"54","author":"F Costa","year":"2005","journal-title":"Gut"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T13:27:39Z","timestamp":1699018059000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288147"}},"subtitle":[],"editor":[{"given":"Joanna","family":"Suliburska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":132,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0288147","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]}}}